Tristetraprolin (TTP or ZFP36) is a tandem CCCH zincfinger RNA-binding protein that regulates the stability of certain AU-rich element (ARE) mRNAs. Recent work suggests that TTP is deficient in cancer cells when compared with normal cell types. In this study we found that TTP expression was lower in invasive breast cancer cells (MDAMB231) compared with normal breast cell lines MCF12A and MCF-10. TTP targets were probed using a novel approach by expressing the C124R zincfinger TTP mutant that functions as dominant negative and increases target mRNA expression. In contrast to wild-type TTP, C124R TTP was able to increase certain ARE-mRNA expressions in serum-stimulated breast cancer cells. Using an ARE-gene microarray, novel targets of TTP regulation were identified, namely, urokinase plasminogen activator (uPA), uPA receptor and matrix metalloproteinase-1, all known to have prominent roles in breast cancer invasion and metastasis. Expression of these targets was upregulated in tumorigenic types, particularly in highly invasive MDAMB231. The mRNA half-lives of these TTP-regulated genes were increased in TTP-knockout embryonic mouse fibroblasts, as assessed using real-time polymerase chain reaction, whereas forced restoration of TTP by transfection led to a reduction in their mRNA levels. RNA immunoprecipitation confirmed an association of TTP, but not C124R, with these target transcripts. Moreover, TTP reduced, whereas the mutant C124R TTP increased, the activity of reporter constructs fused to target ARE. As a result of TTP regulation, invasiveness of MDAMB231 cells was reduced. The data suggest that TTP, in a 3 0 untranslated region-and ARE-dependent manner, regulates an important subset of cancer-related genes that are involved in cellular growth, invasion and metastasis.
Introduction
Breast cancer is the most common type of malignant cancer among women, with a high incidence and mortality rate, and comprises almost a fifth of all female cancers (McPherson et al., 2000) . Cancer metastasis is dependent on the tumor's ability to degrade components of the extracellular matrix by different proteolytic enzymes (Liotta et al., 1980; Liotta, 1986; Bacac and Stamenkovic, 2008) . Alterations in the expression of many genes have been implicated in the invasiveness and metastatic potential of malignant breast cancers (Liotta et al., 1980; Liotta, 1986) . Several gene products of the AU-rich element mRNA (ARE-mRNA) family are overexpressed in cancer cells and such increased expression correlates with increased invasion and metastasis. These include cyclooxygenase 2 (Soslow et al., 2000) , urokinase plasminogen activator (uPA) (Nanbu et al., 1994) , uPA receptor (uPAR) (Roldan et al., 1990) and matrix metalloproteinase 1 (MMP1) (Fini et al., 1987) .
The expression of ARE-mRNA gene products is regulated by RNA-binding proteins, which are transacting factors that bind to AREs and regulate the stability of ARE-mRNAs. Among those is tristetraprolin (TTP), an RNA-binding protein that is rapidly and transiently expressed in response to extracellular stimuli such as serum, growth factors, phorbol esters and insulin (DuBois et al., 1990; Lai et al., 1990) and binds to and destabilizes mRNAs that contain AREs in their 3 0 untranslated regions (UTRs) (Carballo et al., 1998) . TTP is a tandem zinc-finger protein and consists of two zinc-fingers that are necessary for TTP binding to tumor necrosis factor (TNF)-a 3 0 UTR, a major target for TTP . Mutation of either zinc-finger by a single-point mutation (Cys to Arg), for example, C124R mutant, fails to bind TNF-a 3 0 UTR and ARE (Lai et al., 1999) . Well-established targets of TTP involved in cancer have been identified, namely, cyclooxygenase 2 (Sawaoka et al., 2003; Young et al., 2009) and vascular endothelial growth factor (EssafiBenkhadir et al., 2007) . Recently, we have shown that a polyadenylation transcript variant of HuR is an AREmRNA to which wild-type TTP, but not the zinc-finger mutant (C124R), competes with HuR for binding to HuR mRNA itself (Al-Ahmadi et al., 2009a) . Further, TTP mRNA targets have been recently identified, including immediate early response 3 (Lai et al., 2006) and interleukin (IL)-10 (Stoecklin et al., 2008) .
TTP mRNA and protein levels were recently found to be significantly decreased in tumors of the thyroid, lung, ovary, uterus and breast compared with nontransformed tissue samples (Brennan et al., 2009) . Furthermore, loss of TTP expression was observed in several adenomas and adenocarcinomas and correlates with increased expression of HuR and cyclooxygenase 2 (Young et al., 2009) . As a result, TTP dysfunction may lead to abnormalities that contribute to cancer processes.
Our aim was to investigate the role of TTP in global regulation of ARE-gene expression and identify novel TTP-regulated genes in the context of cancer, particularly breast cancer. Observations that the TTP zincfinger mutant C124R can lead to an increase in TNF-a mRNA (Lai et al., 2002) and HuR mRNA expression (Al-Ahmadi et al., 2009a) in an ARE-dependent manner promoted us to further explore this dominant-negative feature. Thus, we used C124R as a biological probe for finding a functional ARE-mRNA repertoire using microarray experiments. We showed that TTP binds to and destabilizes important cancer-related transcripts, namely, MMP1, uPA and uPAR transcripts, in a 3 0 UTR and ARE-dependent manner. We confirmed these targets using different experimental approaches. We also showed that TTP can suppress the invasive potential of breast cancer cells.
Results

TTP mRNA expression in normal and tumor breast cell lines
To compare the expression of endogenous TTP mRNA in normal versus tumor breast cell lines, four different mammary cell lines were used. Estrogen receptor (ER) status was considered when selecting cell lines: one normal and one tumor cell line were chosen that were ER positive (MCF12A and MCF-7, respectively) and similarly one normal and one tumor cell line that did not express ER at detectable levels, namely, MCF10A and MDAMB231. The latter is well known for its increased invasiveness.
To induce the expression of TTP mRNA, serumstarved cell lines were stimulated with serum for 1 and 2 h. TTP mRNA expression in all four cell lines showed a pattern that is typical of TTP, in which mRNA accumulation peaked at 1 h and rapidly decreased to near-basal levels at 2 h (data not shown). A comparison of TTP mRNA expression levels at 1 h was carried out for the four cell lines (Figure 1a ). Normal mammary cell lines, particularly MCF10A, exhibited a high expression of TTP mRNA, when compared with the highly invasive MDAMB231 cell line (Figure 1a) . The ER-negative, nontumorigenic MCF10A cell line showed the highest expression; it was 10-fold higher than MDAMB231 cells that exhibited the least TTP expression of all four cell lines ( Figure 1a) . Similarly, TTP protein expression was much higher in MCF10A cells than in MDAMB231 cells (Figure 2d , upper panel). Several bands with varying mobilities were observed in both cell lines, suggesting different phosphorylation states for TTP. When comparing tumor cell lines, there was a large difference (5.6-fold, P ¼ 0.02) between the noninvasive TTP regulation of AU-rich mRNAs in breast cancer lines N Al-Souhibani et al MCF-7 and the highly invasive MDAMB231 (Figure 1a ). These results suggest that TTP is deficient to a high degree in the highly invasive breast tumor cell line.
Expression of wild-type and mutant TTP and identification of TTP-regulated genes To investigate the gene expression profile effect of the restoration of deficient TTP in the highly invasive breast cell line, MDAMB231, we first determined the optimal functional doses of expression levels of recombinant wild-type and C124R mutant TTP inferred from a cellbased assay with EGFP reporter fused to ARE-3 0 UTR (Figure 1b) . Despite the stability of green-fluorescent protein (GFP), which might mask the actual decrease in the ARE-GFP reporter brought on by TTP destabilization of its mRNA, the effect of wild-type TTP on destabilization of the ARE-GFP reporter was readily detectable and maximal at lower amounts with a 50% reduction in fluorescence at 25 ng compared with control, non-ARE GFP. In contrast, the C124R mutant showed a fourfold increase in reporter activity using the same amount of plasmid. The TTP zinc-finger nonbinding mutant C124R exerts a dominant-negative effect on ARE-mRNA transcripts that results in their increased stabilization (Lai et al., 2002) , and, as a result, overexpression of the mutant C124R TTP construct was used subsequently in microarray experiments in an attempt to more accurately probe ARE-mRNAs signals that are potentially destabilized by TTP but may not be evident because of very low signal intensities in the gene expression microarray. The ARE-complementary DNA microarray Al-Ahmadi et al., 2009b) was used with RNA from HEK293 and MDAMB231 cells overexpressing recombinant TTP and the mutant TTP. There were no detectable basal levels of TTP in these tumor cell lines. Transfection of TTP or its mutant led to the restoration and expression of TTP proteins (Figure 1c) . The C124R mutant did indeed function as dominant negative and increased the gene expression of a subset of ARE-mRNAs ( A volume of 60 mg of total protein was loaded onto sodium dodecyl sulfate-PAGE gel and probed with antibodies against human TTP, uPA, uPAR or b-actin as a loading control.
TTP regulation of AU-rich mRNAs in breast cancer lines N Al-Souhibani et al Abbreviations: TNF, tumor necrosis factor; TTP, tristetraprolin. Genes in bold are those that were down-regulated by TTP and upregulated by C124R.
TTP regulation of AU-rich mRNAs in breast cancer lines N Al-Souhibani et al represent non-ARE genes, and thus their increase is not a primary effect of TTP but most likely due to secondary or unknown mechanisms.
Expression profile of MMP1, uPA and uPAR mRNA in normal and tumor breast cells Within the list of potential TTP targets identified from microarray analysis, there are several genes that code for products that have established roles such as invasion and metastasis in breast cancer, namely, MMP1, uPA and uPAR; therefore, we focused on them for further investigation. We compared expression of these transcripts in the same cell lines that were analyzed for TTP expression. MDAMB231 cells exhibited the highest expression of uPA with a 300-fold increase over ERpositive tumor MCF7 cells and a 10-to 20-fold greater expression than that in normal cell lines (Figure 2a) . However, uPA expression in both normal cell lines was higher than that in MCF7 cells. Similarly, uPAR mRNA expression in MDAMB231 cells was 30-fold higher than that in MCF7 cells and 3-to 5-fold higher than that in normal cells lines, which, in turn, showed a 6-to 12-fold increase in uPAR mRNA expression over MCF7 cells (Figure 2b ). The expression profiles of uPA and uPAR mRNAs are quite similar (Figures 2a and b) , indicating a coordinated expression of these two genes. Subsequently, we examined for the protein expression of uPA and uPAR in ER-negative invasive MDAMB-231 cells in comparison with its normal counterpart, the normal ER-negative breast cell line MCF10A, as these cell lines exhibit the most differential TTP expression both at the mRNA ( Figure 1a Binding characteristics of TTP and mutant TTP to uPA, uPAR and MMP1 mRNAs To determine whether the target mRNAs were actually bound to TTP in vitro, we performed an immunoprecipitation assay of TTP-associated mRNAs using MDAMB231. We found that uPA, uPAR and MMP1 mRNAs were bound to immunoprecipitated TTP protein with a 9-fold, 3-fold and 11-fold increase, respectively, in their anti-TTP-bound RNA precipitate samples over those with immunoglobulin G control (Figure 3a-c) . The nonbinding zinc-finger mutant of TTP gave results similar to immunoglobulin G control, thereby confirming the nonbinding behavior of this mutant protein (Figure 3a-c) .
uPA, uPAR and MMP1 are regulated by TTP in MDAMB231 cells To determine the effect of TTP on endogenous levels of uPA, uPAR and MMP1 mRNA, TTP expression was restored in MDAMB231 cells by transfection of wildtype TTP vector. The time-course curve of uPA gene expression shows that uPA mRNA levels peak at 2 h, returning to baseline levels at 8 h after stimulation of Normal rabbit immunoglobulin G control was used as an antibody control with both TTP and mutant TTP samples. Quantitation of associated mRNA was performed using real-time PCR and normalized to a housekeeping mRNA, RPLPO.
TTP regulation of AU-rich mRNAs in breast cancer lines N Al-Souhibani et al serum (Figure 4a ). The maximum effect of TTP overexpression on uPA mRNA was at 2 h compared with the control. Introduction of TTP resulted in a 45% reduction in uPA mRNA expression compared with cells transfected with vector alone; however, as the transfection efficiency of MDAMB231 cells was approximately 30% as determined by GFP, the actual reduction in mRNA transcripts in completely transfected cells is likely to have been greater. The timecourse induction curve of MMP1, but not that of uPAR, was similar to that of uPA, showing a transient pattern of expression (Figures 4b and c) . The reduction in uPAR and MMP1 mRNA was evident as a result of TTP expression (Figures 4b and c) . These results indicate that restoration of TTP expression in MDAMB231 cells results in a significant reduction in uPA, uPAR and MMP1 mRNAs. Figure 5 ). The patterns of expression were similar for uPA and uPAR in these cell lines, as their mRNAs increase to a maximum at 2 h after induction, after which they decline reaching near-baseline levels after 6 h (Figures 5a and b) . Maximum mRNA levels were achieved in both cell lines 2 h after serum induction in both uPA and uPAR, with a 40% increase in mRNA expression because of TTP knockdown (Figures 5a and  b) . The expression profile of MMP1 in these cell lines was quite different, showing a continuous increase in expression, which reached a maximum at 4 h for TTP À/À and at 6 h for TTP þ / þ cells (Figure 5c ). The greatest difference between the two cell lines is evident at 2 h after induction. In the absence of TTP, MMP1 mRNA levels were 2.5-fold higher compared with those in TTP þ / þ mouse fibroblasts (Figure 5c) . At the protein level, western blotting showed greater protein levels of uPA, uPAR and MMP1 in TTP knockout cells over wild-type cells (Figure 5d ). In fact, TTP þ / þ cells did not show any detectable levels of these proteins.
The mRNA half-life changes of the TTP-regulated transcripts Actinomycin D time course experiments were performed to determine the decay rate of target mRNAs in TTP þ / þ and TTP À/À fibroblasts. We fit these data to a one-phase exponential model, a model that has the best fit (40.9 goodness of fit) for mRNA decay, which tends to plateau after a certain period of time. This method has been recently used by us and others (Vlasova et al., 2008; Al-Ahmadi et al., 2009a) . All tested target mRNAs were unstable with apparent half-lives of less than 1 h (0.5-0.6 h) in the TTP intact wild-type cells (Figure 6 ). Stability was significantly increased by at least 14-fold in the absence of TTP (Figure 6 ). In addition, MMP1 mRNA was highly stabilized in TTP À/À cells (Figure 6c ). 
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Figure 4 TTP regulation of candidate target mRNAs in MDAMB231 cells. MDAMB231 cells were transfected with TTP plasmid or vector control, serum starved overnight, then serum induced for 8 h, after which total RNA was extracted. Endogenous uPA, uPAR and MMP1 mRNA expression levels were measured using real-time PCR and normalized to human RPLPO. The results are means ± s.e.m. of five independent experiments. *Po0.05, **Po0.005 (Student's t test).
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These findings indicate that TTP regulates the decay of uPA, uPAR and MMP1 mRNA transcripts.
TTP effect on uPA, uPAR and MMP1 GFP reporter activity Further evidence of TTP regulation of uPA mRNA as one of the newly identified targets of TTP in this study was provided by experiments using an EGFP reporter construct fused with either TNF-a, uPA, uPAR ARE or the MMP1 3 0 UTR region (Figure 7a ). These constructs were cotransfected with TTP or mutant TTP (C124R) into HEK293 cells. Fluorescence of GFP was measured 24 h after transfection (Figure 7b ) and showed that reporter activity of TNF-a showed a nearly 80% reduction, whereas that of uPA and uPAR was reduced by approximately 60% in cells transfected with TTP compared with control cells. MMP1, the entire 3 0 UTR region of which was used, showed a 20% reduction as a result of TTP transfection. C124R, on the other hand, increased the reporter activity of both TNF-a and uPA ARE (Figure 7b ), indicating the opposite (dominantnegative) effect. The results indicate that TTP regulates the expression of uPA, uPAR and MMP1 mRNAs in an ARE-dependent manner.
TTP effect on invasiveness of MDAMB231 cells
To examine the effect of TTP on the invasiveness of MDAMB231 cells, we transfected these cells with TTP or C124R plasmids and cotransfected with luciferase construct. The cells were then overlaid on matrigel. Luciferase was measured in cells that had invaded the matrigel to the bottom chamber. There was a marked reduction in the invasiveness of TTP-transfected cells compared with either C124R-transfected cells or control cells (Figure 7c) . TTP mutant had a minimal effect on the ability of cells to invade the matrigel.
Discussion
TTP is deficient in many cancer types, including breast cancer; thus, knowledge on TTP induction and regulation of its mRNA targets may lead to new insights into the role of TTP deficiency in cancer processes. In this study, we have identified, through microarray analysis, novel targets of TTP that have prominent roles in cancer invasion and metastasis. It has been shown previously that TTP destabilizes TNF-a, cyclooxygenase 2, vascular endothelial growth factor, IL-2 and IL-10 transcripts (Lai et al., 1999; Sawaoka et al., 2003; Essafi-Benkhadir et al., 2007; Stoecklin et al., 2008; Young et al., 2009 ). This work shows TTP regulation of key cancer-related genes, specifically, uPA, MMP1 and uPAR, in an important malignant breast cancer cell model.
The detection of transcripts with low expression levels, and thus low signals in microarray data, can be problematic if they are further downregulated by experimental treatments (Asyali et al., 2004) . Therefore, in this work, we took advantage of a nonbinding TTP mutant that behaves as dominant negative to probe for targets of TTP-mediated mRNA decay. Comparing the effects of overexpression of TTP and the TTP mutant on ARE-mRNA expression (Table 1) led to a list of potential targets in which effects of both wild-type and mutant TTP are consistent. Some of the transcripts that appear in this list are established targets of TTP, such as IL-10 ( Stoecklin et al., 2008) and colony-stimulating factor Blackshear, 2002) . However, uPA, uPAR and MMP1 are all novel targets of TTP regulation; real-time PCR, immunoprecipitation and use of TTP knockout cells, all confirmed them as TTP targets.
The uPA, uPAR and MMP1 genes were the most significant candidates for TTP regulation, because they all share a common functional role; they are key factors in invasion and metastasis in various types of cancer, including breast cancer (Quax et al., 1990; Christensen et al., 1996; Iwata et al., 1996; Kleiner and StetlerStevenenson, 1999; Fisher et al., 2000; Dass et al., 2008) . uPA is a serine protease that, when bound to its receptor uPAR, converts plasminogen to plasmin, which, in turn, leads to the degradation of the extracellular matrix . MMP1 (also called interstitial collagenase) is a metalloenzyme that also degrades basement membrane components, namely, Type III collagen, in the extracellular matrix, contributing to the invasive and metastatic processes (Liotta et al., 1980; Liotta, 1986) and increased expression of MMP1 results in connective tissue destruction that can lead to many pathological conditions (Vincenti and Brinckerhoff, 2002) .
Posttranscriptional regulation of MMP1, uPA and uPAR mRNA expression takes place because of the presence of AREs in the 3 0 UTR of these transcripts (Roldan et al., 1990; Nanbu et al., 1994 ). An earlier report revealed that the AUUUA motif present in the 3 0 UTR of the collagenase gene destabilized its mRNA and that mutation of AREs led to increased stability of its mRNA transcript (Vincenti et al., 1994) . In addition, ARE-mediated destabilization of uPA and uPAR mRNAs has been reported, although the mediators of this destabilization have not yet been identified (Nanbu et al., 1994; Shetty et al., 1997; Wang et al., 1998) . In fact, a defect in the ARE-mediated decay of uPA mRNA has been implicated in the stability of uPA in certain cell lines, such as MDAMB231 breast cancer cells (Nanbu et al., 1997) . The present results suggest that TTP is a mediator of uPA, uPAR and MMP1 mRNA turnover, which can lead to a reduction in the invasiveness of breast cancer cells.
Overexpression studies have revealed that HuR, an ARE-binding protein that stabilizes mRNA transcripts, stabilizes its own mRNA (Al-Ahmadi et al., 2009a) , in addition to mRNA transcripts of both uPA and uPAR (Tran et al., 2003) . TTP reduces HuR mRNA levels, and competes with HuR-mediated stabilization of HuR mRNA and HuR targets (Al-Ahmadi et al., 2009a) . Thus, TTP action may involve both direct and indirect, HuR-modulated actions. Both HuR expression levels and cytoplasmic localization are increased in many cancer types (de Silanes et al., 2003; Denkert et al., 2004; Mrena et al., 2005; Heinonen et al., 2007) . Concurrently, a loss of TTP expression has been reported in various cancers, such as breast and prostate cancers, as well as in colorectal adenocarcinomas and cancer cell lines, and TTP suppression has been correlated with a negative prognosis (Brennan et al., 2009; Young et al., 2009) . Transcriptional silencing resulting from hypermethylation of CpG islands present in the TTP promoter has been suggested as a mechanism for TTP deficiency in cancer (Young et al., 2009) . A number of miRNAs, such as miR-29a, are overexpressed in tissues of breast cancer patients and target the mRNAs of proteins including TTP, leading to its suppression (Gebeshuber et al., 2009) . Furthermore, in cell lines and tissues in which TTP expression is ubiquitous, hyperphosphorylation of TTP by p38 or ERK has an antagonistic role on the destabilizing activity of TTP, leading to the increased mRNA stability of factors such as vascular endothelial growth factor and IL-8 that promote the progression of tumors (Essafi-Benkhadir et al., 2007; Suswam et al., 2008) . Our results are consistent with published data showing that TTP mRNA and protein expression are deficient in tumor breast cell lines compared with normal cells (Brennan et al., 2009; Young et al., 2009) . Thus, dual TTP deficiency and HuR overexpression may lead to a synergistic increased expression of target mRNAs, such as uPA, uPAR and MMP1, and amplifying further associated cancer processes such as invasion and metastasis.
MMP1, uPA and uPAR mRNAs were expressed highly in breast cancer cell lines, especially in estrogen receptor-negative and highly invasive MDAMB231 cells, and thus ER status may have a role in their expression. The ER-positive status is correlated with decreased invasiveness and metastasis. On the other hand, MMP1 mRNA was virtually undetectable in normal mammary cell lines.
The increased expression of all three transcripts in MDAMB231 cells is expected, given the highly invasive nature of these cells. What was odd, however, was the fact that uPA and uPAR exhibited a higher expression in both ER-positive and ER-negative normal cell lines compared with noninvasive MCF-7 cells. However, this was not the case for MMP1, which was only highly expressed in the invasive-type cell line. Regardless, the findings indicate a relationship between the deficiency of TTP in tumor and metastatic breast cancer cells and the high expression of MMP1, uPA and uPAR.
In summary, MMP1, uPA and uPAR have been shown here to be definite targets of TTP-ARE-mediated degradation. The data suggest that TTP, in a 3 0 UTRand ARE-dependent manner, regulates an important subset of cancer-related genes that are involved in cellular growth, invasion and metastasis. TTP regulation of MMP1, uPA and uPAR mRNA has obvious implications for regulating the invasive and metastatic properties of certain cancer cells. The finding that TTP regulates an important subset of ARE-gene products highly visible in breast cancer, especially invasion and metastasis, has promising implications toward understanding the role of TTP in regulating cancer processes.
Materials and methods
Cell culture and transfection HEK293, MDAMB231 and MCF-7 cell lines were obtained from ATCC and cultured in Dulbecco's Modified Eagle Medium (DMEM, Invitrogen, Carlsbad, CA, USA), supplemented with 10% fetal bovine serum and antibiotics. The normal cell lines of MCF12A and MCF10A cells were cultured in a 1:1 mixture of Ham's F12 and DMEM, supplemented with 0.01 mg ml À1 bovine insulin, 20 ng ml À1 epidermal growth factor and 500 ng ml À1 hydrocortisone. The TTP
and TTP À/À mouse embryonic fibroblasts were previously described (Lai et al., 2006) and were grown in DMEM.
For transfection experiments, cells were transfected with CMV. hTTP.tag, C124RCMV.hTTP.tag or pBS þ (Stratagene, La Jolla, CA, USA) plasmid using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions. After 4-5 h, transfection media were replaced with regular media and incubated overnight. Serum starvation of cells was carried out the following day.
Western blotting
Equal amounts of protein samples were subjected to electrophoresis on 10% polyacrylamide-sodium dodecyl sulfate gels (Protogel, National Diagnostics, Atlanta, GA, USA) or NuPAGE 10%, followed by transfer to nitrocellulose membranes (Hybond ECL, Amersham Biosciences, Little Chalfont, UK). Membranes were hybridized with primary antibody to goat anti-TTP (1/500) (Santa Cruz Biotech, Santa Cruz, CA, USA) or goat anti-uPA (1 mg/ml, human) (Abcam, Cambridge, UK, ab40841) or goat anti-uPAR (1 mg/ml, human) (Abcam, ab3129), or to mouse anti-uPA (1/250, mouse), sheep anti-MMP1 (1/500, Abcam, ab8480) or b actin (1/1000), followed by secondary HRP-conjugated antibody. Signal detection was performed with ECL western blotting detection reagents (Amersham, Piscataway, NJ, USA). Protein molecular weight markers were used to verify the size of the proteins.
Determinations of half-life by the one-phase exponential decay model Serum-stimulated wild-type TTP and knockout MEFs were treated with actinomycin D (5 mg/ml) for increasing periods of time. Total RNA was extracted and subjected to reverse transcription quantitative PCR as in Supplementary Methods. The one-phase exponential decay curve analysis (GraphPad Prism, La Jolla, CA, USA) was used to assess mRNA decay kinetics. The equation Y ¼ Span Â exp (ÀK Â X) þ Plateau describes the kinetics of mRNA decay, where X denotes time and Y the mRNA level (expressed as % remaining after actinomycin D), where Y begins equal starts at Span þ Plateau and decays to Plateau with a rate constant K. Half-life is 0.6932/K. Span and Plateau are expressed in the same units as in the y axis. K is expressed as the inverse of the units used by the x axis. This model is suitable for mRNA determinations in which mRNA levels plateau without dropping to zero and with high regression coefficients, for example, 40.9.
Immunoprecipitation of TTP-associated mRNAs MDAMB231 cells were seeded in 100 Â 20 mm culture dishes at a density of 3.6 Â 10 6 cells per dish and treated as described above. Cells lysed with polysome lysis buffer (100 mM KCl, 5 mM MgCl 2 , 10 mM HEPES, pH 7.0, 0.5% Nonidet P-40) containing RNAse inhibitors and ethylenediaminetetraacetic acid-free proteinase inhibitors and then centrifuged at 14 000 r.p.m. at 4 1C. A total of 100 ml of lysate was incubated for 1-2 h with 100 ml of preswollen A/G agarose beads (Santa Cruz) precoated with 20 mg of anti-TTP or normal rabbit immunoglobulin G (Santa Cruz). The beads were washed with NT2 buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM MgCl 2 and 0.05% NP-40) and then incubated in 100 ml of NT2 buffer containing 20 units of RNAse-free DNAse I to remove genomic DNA contamination, washed, then incubated in 100 ml NT2 buffer containing 0.1% sodium dodecyl sulfate and 0.5 mg/ml proteinase K (15 min, 55 1C) to digest the protein bound to the beads. RNA was subject to TaqMan real-time reverse transcription-PCR as described in Supplementary Methods.
Reporter gene studies EGFP reporter constructs containing 3 0 UTR sequences harboring either the 140 base uPA ARE region, 61 base uPAR ARE region, the entire 3 0 UTR region of MMP1, 64 base TNF-a ARE or a control lacking an ARE region were used in transfection of HEK293 seeded at a density of 3.5 Â 10 4 cells per well in 96-well plates. A total of 30 ng of reporter construct was used and 50 ng of TTP, C124R or PCR3.1 PCR products was cotransfected using Lipofectamine 2000. Fluorescence was measured 24 h after transfection using a Zenith 3100 bottom read fluorescence reader (Anthos Labtec, Eugendorf, Austria).
Invasion assays MDAMB231 cells were seeded in six-well cell culture plates and incubated overnight. Cells were transfected with 0.5 mg of TTP, C124R or PCR3.1 plasmid and cotransfected with 0.25 mg of luciferase PCR product and incubated overnight. The cells were reseeded onto the invasion chamber in serumfree media at a density of 3 Â 10 5 cells per well (24-well BD BioCoat Invasion Chamber, BD Biosciences, MA, USA) and incubated for 24 h. Membranes were removed from the inserts and incubated with luciferase lysis buffer for 15 min, then luciferase dye was added to the lysate and luciferase was measured.
RNA labeling and array hybridization
In Supplementary Methods.
Quantitative reverse transcription-PCR
